Humana experienced a dramatic 69% decline in operating cash flow to $921M alongside a significant membership drop from 16M to 15M medical benefit plan members, while maintaining revenue growth through higher premiums.
The massive operating cash flow decline combined with membership losses suggests deteriorating operational efficiency and potential margin compression despite revenue growth. The company appears to be generating less cash per dollar of revenue, which could indicate rising medical costs or other operational challenges that investors should monitor closely.
Revenue grew a healthy 10.1% to $129.7B, but this was overshadowed by a severe 68.9% collapse in operating cash flow from $3.0B to $921M, forcing management to dramatically reduce share buybacks by 81.5% and build cash reserves (which nearly doubled to $4.2B). Rising interest expense (+22.9%) and SG&A costs (+12.8%) suggest margin pressure, with the overall picture indicating that while Humana is growing its top line, the business is generating significantly less cash and facing operational headwinds that required defensive cash positioning.
Cash position surged 89.1% — strong cash generation or capital raise providing significant financial cushion.
Buyback activity reduced 81.5% — capital being redeployed elsewhere or cash conservation underway.
Operating cash flow fell 68.9% — earnings quality concerns; investigate working capital changes and non-cash items.
Interest costs rose 22.9% — monitor debt levels and coverage ratio in rising rate environment.
SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.
Revenue growing 10.1% — solid top-line momentum, watch margins for quality of growth.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →